Literature DB >> 6446456

Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin.

H Maeda, J Takeshita, A Yamashita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6446456     DOI： 10.1016/0014-2964(80)90215-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Regiospecific O-methylation of naphthoic acids catalyzed by NcsB1, an O-methyltransferase involved in the biosynthesis of the enediyne antitumor antibiotic neocarzinostatin.

Authors:  Yinggang Luo; Shuangjun Lin; Jian Zhang; Heather A Cooke; Steven D Bruner; Ben Shen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

2.  A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.

Authors:  H Maeda; Y Sano; J Takeshita; Z Iwai; H Kosaka; T Marubayashi; Y Matsukado
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 3.  Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.

Authors:  Hiroshi Maeda
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

4.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors:  Hiroshi Maeda; Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.